Tuberculosis following kidney transplantation: Clinical features and outcome. A French multicentre experience in the last 20 years

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3773-3778

  Canet, Emmanuel ^a   Dantal, Jacques ^b   Blancho, Gilles ^b   Hourmant, Maryvonne ^b   Coupel, Stéphanie ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

haemophagocytic syndrome; infection; kidney transplantation; tuberculosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; ETHAMBUTOL; ISONIAZID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; TACROLIMUS;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ASTHENIA; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FEVER; FRANCE; GRAFT SURVIVAL; HEPATITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; NEUROPATHY; OBSERVATIONAL STUDY; OPTIC NEURITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL RATE; WEIGHT REDUCTION;

ADULT; FEMALE; FOLLOW-UP STUDIES; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUBERCULOSIS, PULMONARY;

EID: 80155172644     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr156     Document Type: Article

References (43)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730
2. Gatchalian RA, Leehey DJ. Mortality among patients on dialysis, patients on dialysis awaiting transplantation, and transplant recipients. N Engl J Med 2000; 342: 893-894
3. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004; 351: 2761-2766
4. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612
5. Vo AA, Lukovsky M, Toyoda M et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359: 242-251
6. Moers C, Kornmann NS, Leuvenink HG et al. The influence of deceased donor age and old-for-old allocation on kidney transplant outcome. Transplantation 2009; 88: 542-552
7. Bayat S, Kessler M, Briancon S et al. Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly. Nephrol Dial Transplant 2010; 25: 292-300
8. Coupel S, Giral-Classe M, Karam G et al. Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12 months. Kidney Int 2003; 64: 674-680
9. Morelon E, Stern M, Kreis H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000; 343: 225-226
10. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614
11. Dantal J, Pohanka E. Malignancies in renal transplantation: An unmet medical need. Nephrol Dial Transplant 2007; 22 (Suppl 1): I4-10
12. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007; 370: 2030-2043
13. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S57-S62
14. Janka GE. Hemophagocytic lymphohistiocytosis. Hematology 2005; 10 (Suppl 1): 104-107
15. Blumberg HM, Burman WJ, Chaisson RE et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662
16. Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant 2004; 4: 1523-1528
17. Queipo JA, Broseta E, Santos M et al. Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518-525
18. Aguado JM, Torre-Cisneros J, Fortun J et al. Tuberculosis in solidorgan transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284
19. Hall CM, Willcox PA, Swanepoel CR et al. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435-439
20. John GT, Shankar V, Abraham AM et al. Risk factors for posttransplant tuberculosis. Kidney Int 2001; 60: 1148-1153
21. Sakhuja V, Jha V, Varma PP et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215
22. Apaydin S, Altiparmak MR, Serdengecti K et al. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000; 32: 501-505
23. Naqvi A, Rizvi A, Hussain Z et al. Developing world perspective of posttransplant tuberculosis: Morbidity, mortality, and cost implications. Transplant Proc 2001; 33: 1787-1788
24. Sahn SA, Lakshminarayan S. Tuberculosis after corticosteroid therapy. Br J Dis Chest 1976; 70: 195-205
25. Millar JW, Horne NW. Tuberculosis in immunosuppressed patients. Lancet 1979; 1: 1176-1178
26. Aguado JM, Herrero JA, Gavalda J et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286
27. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002; 17 (Suppl 4): 39-43
28. Shankar MS, Aravindan AN, Sohal PM et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20: 2720-2724
29. Sester M, Sester U, Clauer P et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65: 1826-1834
30. Currie AC, Knight SR, Morris PJ. Tuberculosis in renal transplant recipients: The evidence for prophylaxis. Transplantation 2010; 90: 695-704
31. Naqvi R, Naqvi A, Akhtar S. Use of isoniazid chemoprophylaxis in renal transplant recipients. Nephrol Dial Transplant 2010; 25: 634-637
32. Frieden TR, Sterling TR, Munsiff SS et al. Tuberculosis. Lancet 2003; 362: 887-899
33. Yildiz A, Sever MS, Turkmen A et al. Tuberculosis after renal transplantation: Experience of one Turkish centre. Nephrol Dial Transplant 1998; 13: 1872-1875
34. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solidorgan transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277
35. biomédecine Adl. Rapport d'activité http://www.agence- biomedecine. fr/annexes/bilan2009/donnees/prelevement/01-organes/06greffe- renale/ synthese.php#t5 (2009, date last accessed)
36. Risdall RJ, McKenna RW, Nesbit ME et al. Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993-1002
37. Brastianos PK, Swanson JW, TorbensonMet al. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis 2006; 6: 447-454
38. Buyse S, Teixeira L, Galicier L et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 2010; 36: 1695-1702
39. Ponticelli C, Alberighi OD. Haemophagocytic syndrome-a lifethreatening complication of renal transplantation. Nephrol Dial Transplant 2009; 24: 2623-2627
40. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33
41. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166: 95-109
42. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: Report of 17 cases and review of literature. Transplantation 2004; 77: 238-243
43. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 601-608